title: Determining overdiagnosis by screening with DRE/TRUS or PSA (Florence pilot studies, 1991-1994).
abstract: The rate of overdiagnosis of prostate carcinoma was assessed by following 6890 participants in pilot screening studies from 1991 to 1994. Observed/expected incidence and mortality were determined using data from the Cancer and Mortality Registry. The cancer detection rate (1.75%) and observed/expected ratio (12.5:1) were high at the first screening, and substantially lower at the second screening (0.65% or 4.10:1). According to the registry follow-up, prostate cancer occurred in 225 subjects in the whole study cohort, while 178.2 were expected with 50652 men/years at risk. The standardised incidence rate was 1.66 in the screened (95%CI=1.4-2.0), 0.97 in the non-responders (95%CI=0.8-1.2) and 1.23 in subjects excluded from invitation due to previous cancer or major illness (95%CI=0.8-1.5). A 66% excess incidence rate was observed in the screened subjects over a 9-year period, confirming previous estimates of overdiagnosis.
authors.affiliation: Centro per lo Studio e la Prevenzione Oncologica, Viale A. Volta 171, 50131 Florence, Italy. s.ciatto@cspo.it
authors.forename: Stefano
authors.initials: S
authors.lastname: Ciatto
authors.forename: Ginetta
authors.initials: G
authors.lastname: Gervasi
authors.forename: Rita
authors.initials: R
authors.lastname: Bonardi
authors.forename: Paola
authors.initials: P
authors.lastname: Frullini
authors.forename: Paola
authors.initials: P
authors.lastname: Zendron
authors.forename: Claudio
authors.initials: C
authors.lastname: Lombardi
authors.forename: Emanuele
authors.initials: E
authors.lastname: Crocetti
authors.forename: Marco
authors.initials: M
authors.lastname: Zappa
mesh_terms: D000368:Aged; D015331:Cohort Studies; D003951:Diagnostic Errors; D005240:Feasibility Studies; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000592:standards*; D008875:Middle Aged; D010808:Physical Examination / Q000379:methods; D010865:Pilot Projects; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000401:mortality; D014463:Ultrasonography
chemical_list: D017430:Prostate-Specific Antigen